Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Other ETFs median (248 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 07 May 2025 – 20 Aug 2026, limited by Motilal Oswal Nifty 50 Equal Weight ETF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Motilal Oswal Nifty 50 Equal Weight ETF | Nifty 50 |
|---|---|---|
| 07 May 2025 | ₹100.00 | ₹100.00 |
| 15 Jun 2025 | ₹102.79 | ₹101.25 |
| 24 Jul 2025 | ₹104.38 | ₹102.65 |
| 02 Sep 2025 | ₹104.75 | ₹100.68 |
| 11 Oct 2025 | ₹107.63 | ₹103.57 |
| 19 Nov 2025 | ₹110.35 | ₹106.71 |
| 28 Dec 2025 | ₹110.32 | ₹106.67 |
| 05 Feb 2026 | ₹110.70 | ₹105.03 |
| 16 Mar 2026 | ₹102.32 | ₹95.88 |
| 25 Apr 2026 | ₹107.05 | ₹97.88 |
| 03 Jun 2026 | ₹107.24 | ₹95.87 |
| 12 Jul 2026 | ₹109.70 | ₹99.15 |
| 20 Aug 2026 | ₹111.02 | ₹99.25 |
| Metric | Motilal Oswal NAV ₹33.57 Very High risk ★★★★☆ 1Y | Category median Other ETFs · 248 funds |
|---|---|---|
| +4.94% | +3.65% | |
| — | +10.51% | |
| — | +9.28% | |
| — | +11.93% | |
| +8.46% | +10.38% | |
| +5.25% | — | |
| — | +14.30% | |
| — | +13.74% | |
| — | +12.83% | |
| Risk | ||
| 13.22% | 15.45% | |
| -0.12 | 0.28 | |
| -0.17 | 0.41 | |
| -12.44% | -20.59% | |
| Nifty 50 | — | |
| — | +0.80% | |
| — | 1.00 | |
| — | 102.1% | |
| — | 96.4% | |
| 0.16% | 0.32% | |
| ₹128.52Cr | ₹137.31Cr | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| Dishant Mehta | — | |
| 07 May 2025 | — | |
| 50 | — | |
| 22.3% | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.